Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Low dose of ecstasy reduces people’s ability to recognize sad faces: study

by Eric W. Dolan
August 14, 2014
in Psychopharmacology
(Photo credit: Caesar Sebastian)

(Photo credit: Caesar Sebastian)

Share on TwitterShare on Facebook

Methylenedioxymethamphetamine — the drug commonly known as ecstasy or molly — increases emotional empathy and reduces the recognition of sad faces while having no effect on moral judgments, according to new research.

In the study, published in the Journal of Psychopharmacology, researcher Yasmin Schmid and her colleagues observed that “the positive bias in emotion recognition and increase in emotional empathy induced by even a low dose of MDMA likely contribute to its popularity as a recreational drug.”

The double-blind, placebo-controlled study of 30 healthy individuals utilized the Facial Emotion Recognition Task, Multifaceted Empathy Test, Movie for the Assessment of Social Cognition, Social Value Orientation Test, and Moral Judgment Task to examine the effects of MDMA on several aspects of social cognition.

The study found that the individuals who consumed a low dose of MDMA were able to accurately infer the mental states of others in various circumstances, but tended to misclassify faces with negative expressions. MDMA had no effect on the judgment of moral dilemmas, but the drug did increase ratings in happiness, openness, trust and closeness to others.

“The main findings of the present study were that a low dose of MDMA enhanced emotional empathy for positive emotional stimuli on the MET and tended to reduce the recognition of sad faces on the FERT. The positive bias in emotion recognition and increase in emotional empathy induced by a low dose of MDMA were accompanied by only moderate subjective effects. MDMA had no acute effects on cognitive empathy on the MET or mental perspective-taking on the MASC, indicating that MDMA did not acutely alter complex social cognitive inferences,” the researchers wrote.

MDMA is often described as an “empathogen” because of its ability to amplify pro-social behaviors and feelings. The bias against recognizing negative facial expressions likely plays a role.

“A similar alteration in affect recognition, in which faces were more often mistakenly judged as neutral, particularly in response to sad facial expressions, was also found after moderate alcohol consumption. Drugs that facilitate social approach behaviour may do so by partially decreasing the correct identification of threat-related or negative facial emotion signals,” Schmid and her colleagues said.

Google News Preferences Add PsyPost to your preferred sources
Previous Post

Treating mental illness by changing memories of things past

Next Post

Biomarker could reveal why some develop post-traumatic stress disorder

RELATED

Democrats dislike Republicans more than Republicans dislike Democrats, studies find
Ayahuasca

A single dose of DMT reverses depression-like symptoms in mice by repairing brain circuitry

March 8, 2026
Stimulant medications normalize brain structure in children with ADHD, study suggests
ADHD Research News

Long-term ADHD medication use does not appear to permanently alter the developing brain

March 5, 2026
Hemp-derived cannabigerol shows promise in reducing anxiety — and maybe even improving memory
Alcohol

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

March 5, 2026
New psychology research flips the script on happiness and self-control
Cannabis

Exploring the motivations for cannabis use during sex

March 4, 2026
Chocolate lovers’ brains: How familiarity influences reward processing
Cognitive Science

A single dose of cocoa flavanols improves cognitive performance during aerobic exercise

March 4, 2026
Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”
Ayahuasca

Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”

March 4, 2026
New research: AI models tend to reflect the political ideologies of their creators
Neuroimaging

Psilocybin produces different behavioral and brain-altering effects depending on the dose

February 26, 2026
Consumption of gluten harms the hypothalamus region of the brain in male mice and may lead to obesity, study finds
Ketamine

Ketamine blocks the short-term anxiety and social withdrawal linked to adolescent social defeat

February 25, 2026

STAY CONNECTED

LATEST

Supportive relationships are linked to positive personality changes

Brain-controlled assistive robots work best when they share the workload with users

Common airborne chemicals are linked to suicidal thoughts in a new public health study

New research sheds light on the psychological recipe for a grudge

Eating ultra-processed foods is not linked to faster mental decline, study finds

Hypocrisy and intolerance drive religious doubt among college students

A single dose of DMT reverses depression-like symptoms in mice by repairing brain circuitry

Apocalyptic views are surprisingly common among Americans and predict responses to existential hazards

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc